Biora Therapeutics, Inc. Operating Lease Liability
Biora Therapeutics, Inc. had Operating Lease Liability of $1.05 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-11-14
- 2024-09-30: Operating Lease, Liability $1.05M.
- 2024-06-30: Operating Lease, Liability $1.28M.
- 2024-03-31: Operating Lease, Liability $1.50M.
- 2023-12-31: Operating Lease, Liability $1.71M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-09-30 | $1.05M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.28M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.71M 10-K · filed 2024-04-01 |
| 2023-09-30 | $2.01M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.94M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.22M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.49M 10-K · filed 2023-03-30 |
| 2022-09-30 | $1.88M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.15M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.53M 10-Q · filed 2022-05-10 |